LRMR earnings: a negative outcome, -7.9%

-7.9%Larimar Therapeutics, Inc. (LRMR) →

On May 12, 2022, Larimar Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.9% in the window around the event. It had already run -10.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$2.78

1d before

$2.56

Event day

$2.55

1d after

$2.51

5d after

Pre-catalyst setup

-10.9%

30-day run-up

9055%

30-day volatility

0.6×

volume spike

LRMR catalyst calendar More earningss Prediction track record Full catalyst calendar